Frontiers in Cardiovascular Medicine

FEBRUARY 14, 2024

Background Pulmonary embolism is a condition of right cardiac dysfunction due to pulmonary circulation obstruction. Malignant tumor-induced pulmonary embolism, which has a poor therapeutic outcome and a significant impact on hemodynamics, is the cause of sudden death in patients with malignant tumors.

Embolism 64

Embolism Pulmonary Blood Pressure Hospital 64

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

However, conventional surgical and transcatheter arterial embolization treatments are less effective. In the present case, a 76-year-old hypertensive woman was admitted with dizziness and diagnosed with an unruptured bronchial artery aneurysm, which was treated by transcatheter arterial embolization and aortic stent-graft.

Embolism 59

Embolism Aneurysm Stents Stent 59

Stroke Journal

FEBRUARY 1, 2024

Introduction:Middle meningeal artery embolization for chronic subdural hematomas is a promising treatment either as an adjuvant to surgical evacuation of the hematoma or as a primary treatment modality. A total of 67 patients (42%) were treated with particles and 93(58%) with liquid embolic agents. mm, p<0.59).Conclusions:The

Embolism 40

Embolism Stroke Strokes Outcomes 40

The American Journal of Cardiology

OCTOBER 29, 2024

Publication date: Available online 28 October 2024 Source: The American Journal of Cardiology Author(s): Aryan Mehta, Mridul Bansal, Siddhant Passey, Saurabh Joshi, Carlos L Alviar, Jason N Katz, J Dawn Abbott, Saraschandra Vallabhajosyula

Embolism 40

Embolism Pulmonary Outcomes 40

Frontiers in Cardiovascular Medicine

MARCH 27, 2024

In this case report, we demonstrated that thrombus aspiration and in situ thrombolysis through the Guidezilla GEC are applicable to patients with PE in whom systemic thrombolysis is contraindicated, resulting in successful reperfusion and positive clinical outcomes.

Thrombolysis 64

Thrombolysis Embolism Pulmonary Anatomy 64

Circulation: Cardiovascular Interventions

JANUARY 24, 2024

BACKGROUND:Prior clinical trials have demonstrated the efficacy of ultrasound-facilitated catheter-directed thrombolysis (USCDT) for the treatment of acute intermediate-risk pulmonary embolism (PE) using reduced thrombolytic doses and shorter infusion durations.

Embolism 75

Embolism Thrombolysis Ultrasound Pulmonary 75

Frontiers in Cardiovascular Medicine

DECEMBER 20, 2023

Massive pulmonary embolism (MPE) carries significant 30-day mortality and is characterized by acute right ventricular failure, hypotension, and hypoxia, leading to cardiovascular collapse and cardiac arrest. Considerable heterogeneity in studies is a significant weakness of the available literature.

Embolism 72

Embolism Pulmonary Cardiac Arrest Hemorrhage 72

Frontiers in Cardiovascular Medicine

JULY 1, 2024

Notably, acute massive pulmonary embolism (PE) with bilateral atrial thrombosis is an exceptional occurrence in CAPS. Acute pulmonary embolism (PE) is a common cardiovascular disease that progresses rapidly and has a high mortality rate. It primarily affects small vessels, seldom impacting large vessels.

Thrombosis 52

Thrombosis Embolism Pulmonary Laboratory 52

HCPLive

SEPTEMBER 1, 2024

Asundexian failed to prove noninferiority to apixaban for its primary efficacy outcome in the phase 3 OCEANIC-AF trial.

Embolism 69

Embolism Stroke Strokes Outcomes 69

Frontiers in Cardiovascular Medicine

MARCH 27, 2024

Common embolism sites include the brain, spleen, kidneys, lungs, and intestines. Additionally, acute heart failure (AHF) can occur in up to 40% of cases, and its presence can impact the clinical outcomes of patients with IE. Cardiogenic shock (CGS) is often more likely to occur after AHF has taken place.

Cardiogenic Shock 64

Cardiogenic Shock Embolism Heart Failure Thrombosis 64

Stroke Journal

FEBRUARY 1, 2024

The purpose of this study was to compare the outcomes of EVT for ICAD with those of cardiogenic cerebral embolism (CE) based on real-world data from a multicenter, prospective registry study (K-NET registry) involving 40 centers in Japan.Methods:The K-NET study enrolled 3187 EVTs in 2018-2021, of which 358 (11%) were ICAD and 1870 (59%) were CE.

Embolism 40

Embolism Outcomes Hemorrhage Angioplasty 40

JAMA Cardiology

NOVEMBER 21, 2023

This cohort study assesses outcomes in patients with pulmonary embolism using high-sensitivity vs conventional troponin I.

Embolism 40

Embolism Pulmonary Outcomes 40

Journal of the American Heart Association

JANUARY 19, 2024

BackgroundCerebral embolic protection devices (CEPD) capture embolic material in an attempt to reduce ischemic brain injury during transcatheter aortic valve replacement. Primary clinical outcome was all‐cause stroke. Secondary clinical outcomes were disabling stroke and all‐cause mortality.

Aortic valve 40

Aortic valve Embolism Aortic Stroke 40

Frontiers in Cardiovascular Medicine

FEBRUARY 22, 2024

Aims Perioperative stroke remains a devastating complication after transcatheter aortic valve implantation (TAVI), and using a cerebral embolic protection device (CEPD) during TAVI may reduce the occurrence of stroke according to some studies.

Aortic valve 64

Aortic valve Embolism Aortic Stroke 64

Heart BMJ

MAY 10, 2024

Objectives The use of cerebral embolic protection (CEP) during transcatheter aortic valve implantation (TAVI) has been studied in several randomised trials. The primary outcome was the risk of disabling stroke. The minimal clinically important difference was determined at 1.1% ARD, per expert consensus (NNT 91).

Aortic valve 52

Aortic valve Embolism Aortic Stroke 52

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Middle meningeal artery embolization (MMAE) is a promising minimally invasive alternative with an estimated surgical recurrence rate of 6.8% Primary outcome is defined as the proportion of patients that require rescue surgery or die within 180 days. for standalone MMAE and combined MMAE and surgery respectively.

Embolism 40

Embolism Outcomes Stroke Strokes 40

Dr. S. Venkatesan MD

OCTOBER 15, 2024

A new Intelligent thrombo-suction catheter system , is being introduced for treatment of acute pulmonary embolism.This device regulates the force with which thrombus is sucked , with less injury and bleeding and better outcomes. Human studies & Evidence The experience from this device was presented in ESC 2024 London.

Technology 52

Technology Pulmonary Embolism Innovation 52

Stroke Journal

FEBRUARY 1, 2024

Previous studies have noted that ICAD-related LVOs, compared to embolic occlusions, have longer procedural times and lower successful reperfusion rates. However, clinical outcomes remain similar. Patient outcomes at 3 months were assessed using modified Rankin Scale (mRS) scores, defining devastating outcomes as mRS 5-6.

Outcomes 40

Outcomes Embolism Atrial Fibrillation Thrombolysis 40

ECG Cases

NOVEMBER 6, 2018

This Best Case Ever elucidates the practical challenges of working up pregnant patients in the ED with a suspicion of pulmonary embolism. Since this recording, the first ever multi-center prospective outcome study looking at the pulmonary embolism workup in pregnancy was published in the Annals of Internal Medicine.

Embolism 52

Embolism Pulmonary Outcomes Ultrasound 52

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

The inflow aneurysms were accessed and embolized with coils using a second microcatheter prior to AVM embolization. Extensive but partial filling of the AVM was noted anteriorly but full embolization of the posterior aspect of the nidus was not achieved. Onyx‐18 was then injected into the main AVM pedicle under a blank roadmap.

Aneurysm 40

Aneurysm Embolism Hemorrhage Hypertension 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

We present a single‐center experience describing the characteristics and outcomes of treated and untreated IIAs.MethodsThis is a single‐center retrospective observational study of patients admitted with IE who developed IIAs and were admitted at our institute from 2016 to 2022. underwent n‐BCA embolization, 14.2% 9); (P=0.002).

Aneurysm 40

Aneurysm Embolism Outcomes Hospital 40

Circulation: Cardiovascular Interventions

FEBRUARY 27, 2024

In this study, we assessed the clinical predictors and outcomes of advanced therapy compared with anticoagulation alone for the acute management of right heart thrombus.Methods:In this observational cohort study, we analyzed consecutive patients who were treated for right heart thrombus. The primary end point was 90-day all-cause mortality.

Outcomes 40

Outcomes Thrombolysis Embolism Pulmonary 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionThe use of detachable coils for endovascular embolization of cerebral aneurysms has become a safe and effective alternative to direct surgical clipping in patients with ruptured aneurysmal subarachnoid hemorrhage. Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023.

Aneurysm 40

Aneurysm Stents Stent Hemorrhage 40

DAIC

FEBRUARY 9, 2024

According to researchers, complications related to the embolization procedure were low, and neurological function was comparable to those without embolization. The primary outcome was how frequently there was reaccumulation of blood (a recurrence) that required surgical drainage within 90 days. of those who had surgery alone.

Embolism 115

Embolism Research Strokes Stroke 115

Stroke Journal

FEBRUARY 1, 2024

We isolated a cohort of patients with likely embolic PCA occlusions (those with atrial fibrillation) and compared outcomes associated with IVT and EVT versus medical management (MM).Methods:The Patterns were also similar when patients with a concomitant BAO were included (routine discharge adjusted OR for IVT: 1.57, 95% CI:1.03-2.38).Conclusion:Our

Atrial Fibrillation 40

Atrial Fibrillation Thrombolysis Outcomes Embolism 40

Journal of the American Heart Association

NOVEMBER 28, 2023

Although the clinical outcomes and economic burdens of VTE have been well described, the impact of VTE on patients' health status has yet to be summarized. After screening and exclusion, 136 references were identified; 5 described PROM development, 20 focused on PROM validation, and 111 used PROMs in outcomes research.

Quality of Life 40

Quality of Life Outcomes Embolism Pulmonary 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

3 The third‐generation iteration of the Pipeline Embolization Device (PED) incorporates Shield technology, a phosphorylcholine coating designed to reduce thrombogenicity via mimicry of native cell membranes.4 IntroductionIndications for flow diversion for the treatment of cerebral aneurysms have increased remarkably in recent years.1

Embolism 40

Embolism Aneurysm Hemorrhage Stents 40

Journal of the American Heart Association

FEBRUARY 23, 2024

BackgroundIn patients with acute cardiogenic cerebral embolism, a residual thrombus may still be present in the cardiac cavity even after reperfusion therapy. The primary outcome was a poor clinical outcome (modified Rankin Scale score, 3–6) at 90 days. Journal of the American Heart Association, Ahead of Print. versus 31.1%;P=1.000).ConclusionsResidual

Stroke 40

Stroke Strokes Outcomes Myocardial Infarction 40

Stroke Journal

FEBRUARY 1, 2024

NT-proBNP significantly predicted recurrent stroke; recurrent ischemic stroke or systemic embolism; and recurrent stroke or death after adjusting for other risk factors, while PTFV1 and LADI did not (Table). Recurrent stroke occurred in 80 patients (annualized rate, 4.4%) and death in 54 patients.

Biomarkers 40

Biomarkers Stroke Strokes Outcomes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

We studied the effects of COA treatment with FD alone or in combination with coil embolization, based on the origin of the ophthalmic artery in‐relation to the aneurysm sac.MethodsRetrospective analysis of a prospectively collected tertiary center database. directly from the aneurysm fundus, B. aneurysm neck, C. aneurysm neck, C.

Aneurysm 40

Aneurysm Outcomes Embolism Stents 40

American College of Cardiology

APRIL 16, 2024

What are the in-hospital and readmission outcomes in patients with intermediate-risk or high-risk pulmonary embolism (PE) treated with versus without catheter-based therapies (CBTs) in a large retrospective registry?

Embolism 56

Embolism Pulmonary Hospital Outcomes 56

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

With the advancement of endovascular coil devices, aneurysm embolization with coiling is becoming the more preferred treatment approach compared to craniotomy with microsurgical clipping. Primary outcomes were functional status recorded as modified Rankin scores (mRS) and radiographic occlusion rates documented as Raymond‐Roy scores.

Aneurysm 40

Aneurysm Embolism Stents Stent 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

However, IVT's efficacy on stent retriever (SR) and aspiration thrombectomy (ASP) outcomes specifically remain unclear. Moreover, our results indicate that administration of IVT before MT may improve certain outcomes based on the used first‐line MT technique. ResultsWe included four randomized controlled trials with 1176 patients.

Thrombolysis 40

Thrombolysis Outcomes Embolism Stents 40

Open Heart

MAY 11, 2023

The aim of our study was to investigate factors associated with patient refusal of anticoagulation and the clinical outcomes in these patients. Further research is required to understand the patient profile and mortality outcome of patients who refuse anticoagulation.

Outcomes 52

Outcomes Blood Pressure Atrial Fibrillation Embolism 52

Circulation

NOVEMBER 11, 2024

The percentage of time in the therapeutic range (TTR) was used as the primary outcome while bleeding, thrombosis, and other events were the secondary outcomes.Results:A total of 721 patients were enrolled. 1.09; P < 001) and reduced the bleeding and embolic risk by 6% (OR 0.94, 95% CI 0.92-0.96;

Heart Valves 40

Heart Valves Embolism Thrombosis Quality of Life 40

Open Heart

MARCH 1, 2024

The primary outcome was major bleeding resulting in hospitalisation based on International Classification of Diseases (ICD)-10 codes. Secondary outcomes included intracranial bleeding, gastrointestinal bleeding and other bleeding. Propensity score matching was performed, and matched cohorts were compared using Cox proportional HRs.

Atrial Fibrillation 52

Atrial Fibrillation Embolism Outcomes Stroke 52

Journal of the American Heart Association

JANUARY 31, 2024

The primary outcomes were ischemic stroke, systemic embolic events, and hospitalization for major bleeding. The secondary outcomes were intracranial hemorrhage, hospitalization for gastrointestinal bleeding, all‐cause mortality, and a composite outcome. The median follow‐up duration was 2.4 1.06];P=0.11). 1.06];P=0.11).

Atrial Fibrillation 40

Atrial Fibrillation Tricuspid Embolism Hemorrhage 40